Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH. Faessel HM, et al. J Clin Pharmacol. 2006 Sep;46(9):991-8. doi: 10.1177/0091270006290669. J Clin Pharmacol. 2006. PMID: 16920893 Clinical Trial.
Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males.
MacLean DB, Shi H, Faessel HM, Saad F. MacLean DB, et al. Among authors: faessel hm. J Clin Endocrinol Metab. 2015 Dec;100(12):4579-87. doi: 10.1210/jc.2015-2770. Epub 2015 Oct 26. J Clin Endocrinol Metab. 2015. PMID: 26502357 Free PMC article. Clinical Trial.
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation.
Ravva P, Gastonguay MR, French JL, Tensfeldt TG, Faessel HM. Ravva P, et al. Among authors: faessel hm. Clin Pharmacol Ther. 2010 Mar;87(3):336-44. doi: 10.1038/clpt.2009.282. Epub 2010 Jan 27. Clin Pharmacol Ther. 2010. PMID: 20107434 Clinical Trial.
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.
Feng B, Obach RS, Burstein AH, Clark DJ, de Morais SM, Faessel HM. Feng B, et al. Among authors: faessel hm. Clin Pharmacol Ther. 2008 Apr;83(4):567-76. doi: 10.1038/sj.clpt.6100405. Epub 2007 Oct 31. Clin Pharmacol Ther. 2008. PMID: 17971819 Clinical Trial.
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.
Faessel HM, Burstein AH, Troutman MD, Willavize SA, Rohrbacher KD, Clark DJ. Faessel HM, et al. Eur J Clin Pharmacol. 2008 Nov;64(11):1101-9. doi: 10.1007/s00228-008-0530-6. Epub 2008 Jul 26. Eur J Clin Pharmacol. 2008. PMID: 18661125 Clinical Trial.
Varenicline: new treatment with efficacy in smoking cessation.
Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watsky E, Reeves K. Reus VI, et al. Among authors: faessel h. Drugs Today (Barc). 2007 Feb;43(2):65-75. doi: 10.1358/dot.2007.43.2.1069956. Drugs Today (Barc). 2007. PMID: 17353944 Review.
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Faessel H, Ravva P, Williams K. Faessel H, et al. Clin Ther. 2009 Jan;31(1):177-89. doi: 10.1016/j.clinthera.2009.01.003. Clin Ther. 2009. PMID: 19243716 Clinical Trial.
Varenicline overdose in a teenager--a clinical pharmacology perspective.
Rollema H, Faessel HM, Williams KE. Rollema H, et al. Among authors: faessel hm. Clin Toxicol (Phila). 2009 Jul;47(6):605. doi: 10.1080/15563650902970689. Clin Toxicol (Phila). 2009. PMID: 19586362 No abstract available.
Population pharmacokinetic analysis of varenicline in adult smokers.
Ravva P, Gastonguay MR, Tensfeldt TG, Faessel HM. Ravva P, et al. Among authors: faessel hm. Br J Clin Pharmacol. 2009 Nov;68(5):669-81. doi: 10.1111/j.1365-2125.2009.03520.x. Br J Clin Pharmacol. 2009. PMID: 19916991 Free PMC article.
Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.
Ravva P, Gastonguay MR, Faessel HM, Lee TC, Niaura R. Ravva P, et al. Among authors: faessel hm. Nicotine Tob Res. 2015 Jan;17(1):106-13. doi: 10.1093/ntr/ntu154. Epub 2014 Aug 21. Nicotine Tob Res. 2015. PMID: 25145377 Free PMC article. Clinical Trial.
23 results
Jump to page